Clinical Trials Logo

Hysterectomy clinical trials

View clinical trials related to Hysterectomy.

Filter by:

NCT ID: NCT01552148 Completed - Hysterectomy Clinical Trials

Transversus Abdominis Plane Block for Laparoscopic Hysterectomy

Start date: March 2012
Phase: Phase 4
Study type: Interventional

Purpose To evaluate whether adding a transversus abdominis plane block in patients undergoing elective laparoscopic hysterectomy reduces Patient-controlled analgesia (PCA) morphine requirements during the first 24 hours postoperatively. Forty-six patients undergoing laparoscopic hysterectomy will be randomized into two groups: 1. Group treatment TAP (n=23) will receive the following analgesia: - US guided transversus abdominis plane block performed with 40ml of 0.375% levobupivacaine (20 ml per side) after general anaesthesia induction, before surgical start - Morphine PCA with loading dose i.v. titrated by the PACU nurse if pain > 5/10 at rest 2. Group control will receive: - Morphine PCA with loading dose i.v. titrated by the PACU nurse if pain > 5/10 at rest Primary Outcome Measures: Morphine consumption (mg) (Time Frame: 24 hours) in Groups TAP and Control Secondary Outcome Measures: - Pain at rest and during movement quantified as Numerical Rating Scores (0-10) for pain when resting in bed and during cough during the first 24 hours postoperatively - Time to PACU dimission, evaluated as patient's achievement of a White's score > or = 12/14 - Time to home discharge, evaluated as patient's achievement of a PADDS score > or = 9 - Functional patient capacity as measured before surgery and whenever a White's score > or = 12 will be reached (2minute walking test) - Eventual side effects such as nausea/vomiting

NCT ID: NCT01526668 Completed - Pain Clinical Trials

Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy

POSTHYSTREC
Start date: October 11, 2011
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the effect of four different follow-up strategies on postoperative recovery following vaginal or abdominal hysterectomy for benign conditions. Furthermore the investigators aim to examine associations between preoperative thresholds for pain (thermal and pressure) and postoperative pain and development of chronic pelvic pain after benign hysterectomy.

NCT ID: NCT01511627 Withdrawn - Hysterectomy Clinical Trials

Randomized Controlled Trial Comparing Postoperative Pain Following TAH With GA vs. Combined GA + SAB

Start date: January 2012
Phase: N/A
Study type: Interventional

The investigators hypothesize that a spinal anesthetic administered prior to the induction of general anesthesia will result in reduced need for pain medication and reduced postoperative pain, as well as reduced hospital stay following a total abdominal hysterectomy.

NCT ID: NCT01504386 Terminated - Hysterectomy Clinical Trials

Transversus Abdominis Plane Block After Robot-assisted Laparocopic Hysterectomy

TAP-block
Start date: December 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the effectiveness of Transversus Abdominis Plane (TAP) block as a part of a multimodal postoperative pain management after robot-assisted laparoscopic hysterecomy.

NCT ID: NCT01199159 Completed - Hysterectomy Clinical Trials

Preoperative Misoprostol in Reducing Blood Loss in Total Abdominal Hysterectomy (TAH)

Start date: January 2007
Phase: N/A
Study type: Interventional

Total abdominal hysterectomy is known to be associated with operative blood loss, which can lead to patients' morbidity. Misoprostol, a prostaglandin, has been shown to be effective in reducing operative blood loss during myomectomy. It is the first study to investigate if preoperative misoprostol is effective in reducing operative blood loss during total abdominal hysterectomy.

NCT ID: NCT01182714 Completed - Hysterectomy Clinical Trials

A Prospective Randomized Control Trial Comparing Immediate and 24-hours Delayed Catheter Removal Following Hysterectomy

Start date: November 2007
Phase: N/A
Study type: Interventional

Total abdominal hysterectomy is a common gynaecological operation performed worldwide. In Hong Kong, it was the most common gynaecological open procedure done and the number of hysterectomies performed increased by almost 50% in 2004 when compared to 1999. In-dwelling catheter use after uncomplicated abdominal hysterectomy has been the standard method for bladder treatment after the operation. It is traditionally advocated to assess urinary output and to prevent post-operative urinary retention as patients with abdominal wound are unable to increase the intra-abdominal pressure to aid voiding. However, in-dwelling catheters have been associated with increased white cell counts and higher rates of positive urine cultures, and subsequently urinary tract infection can lead to increased morbidity, duration of hospital stay, and overall healthcare cost. Duration of catheter use post-operatively is generally based on custom rather than evidence-based knowledge and therefore varies considerably. The current practice of the investigators hospital is to leave an in-dwelling catheter in-situ for 24 hours after an uncomplicated open gynaecological surgery. Schiotz et al showed that twenty-four-hour catheterization after common gynaecological procedures was associated with a low rate of voiding problems after catheter removal. Post-operative urinary retention leading to bladder atony may increase the long-term morbidity through increased risk of infection, detrusor instability and voiding difficulties. In-dwelling catheter in the immediate post-operative period will help to combat this problem. However, this has to be balanced against the potential risk of catheter-associated urinary tract infection which varies from 5% to 43% in the published trials. A prospective randomized study comparing immediate versus delayed catheter removal following hysterectomy showed that delayed removal after operation was not associated with an increased rate of febrile events or urinary tract infections, but a significantly higher subjective pain assessment. The size of the catheter used was 16F which was not the standard 12F that the investigators used in the investigators hospital setting. It is postulated that if a smaller caliber in-dwelling catheter is used, it will not result in an increased subjective pain assessment, and the catheter can be left in-situ for 24 hours without causing increased adverse outcomes but possibly reducing recatheterisation rate post-operatively.

NCT ID: NCT01127243 Completed - Hysterectomy Clinical Trials

Day-case Versus Inpatient Laparoscopic Supracervical Hysterectomy

Start date: June 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if women subjected to laparoscopic supracervical hysterectomy in a day-case setting would be less satisfied with the length of hospital stay when compared with women who had an overnight stay following their surgical procedure. The null hypothesis was that there was no difference in satisfaction with length of hospital stay.

NCT ID: NCT01106547 Completed - Postoperative Pain Clinical Trials

The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy

Start date: August 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effect of 125 mg methylprednisolone, given intravenously 60-90 minutes before abdominal surgery,on the postoperative rehabilitation after abdominal hysterectomy.Sodium Chloride is the placebo. The following parameters are registered: 1. Pain 3, 6 and 24 hours postoperatively and 2-7 days after surgery. 2. The postoperative use of additional analgesics. 3. Inflammatory parameters before and after surgery. 4. Time until mobilization. 5. Time until discharge.

NCT ID: NCT01084161 Completed - Hysterectomy Clinical Trials

Study to Evaluate the Efficacy, Safety and Tolerability of N1539

Start date: March 2010
Phase: Phase 2
Study type: Interventional

To determine the analgesic efficacy, duration of effect, and safety of single doses of N1539 in subjects undergoing open abdominal hysterectomy

NCT ID: NCT01007305 Completed - Hysterectomy Clinical Trials

Bilateral Oophorectomy Versus Ovarian Conservation

Start date: May 2009
Phase: N/A
Study type: Interventional

This is a pilot study to assess the feasibility of conducting a randomized, blinded, controlled trial of bilateral salpingo-oophorectomy (BSO, removal of the ovaries and fallopian tubes) versus ovarian conservation among premenopausal women age 40 years and greater who plan to undergo hysterectomy for a benign gynecologic condition. Subjects will be randomized to BSO or ovarian conservation concomitant with hysterectomy and remain blinded to group assignment. The primary goal of this pilot is to determine the feasibility of recruiting and retaining study participants in anticipation of conducting a larger, multi-centered trial. However, the investigators will also obtain baseline data and follow-up measures at 6 weeks and 6 months after surgery. Outcomes will be assessed in several domains that the investigators hypothesize may be effected by oophorectomy: cardiovascular health, skeletal health, sexual functioning, and health-related quality-of-life.